Exosome: A Novel and Safer Therapeutic Refinement of Mesenchymal Stem Cell
Mesenchymal stem cell (MSC) has just been approved as the first “off-the-shelf” stem cell pharmaceutical drug with an anticipation of more approvals following completion of numerous rigorous clinical trials. Despite this progress, the rationale for MSC therapeutic efficacy remains tenuous and is inc...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AboutScience Srl
2013-01-01
|
| Series: | Journal of Circulating Biomarkers |
| Online Access: | https://doi.org/10.5772/57460 |